How to improve outcomes of your viral vectors for gene therapy with high-quality data from biophysical profiling methods

November 4, 2021

Optimizing your vectors for gene therapy is a daunting task. When developing and optimizing AAVs, concerns such as serotype, storage stability, expression method, and genetic fill level must be addressed before a therapeutic vector reaches clinical application. With biophysical characterization tools, it is possible to address these questions and determine the best formulation for your AAV development needs. The proper tool will give you the high-quality data you require, without using lots of precious sample. Watch this video to learn how NanoTemper is addressing the needs of gene therapy researchers.

Previous Video
Overcome bottlenecks in viral vector manufacturing
Overcome bottlenecks in viral vector manufacturing

The success of your gene therapy vectors is dependent on optimal formulation conditions. Finding a buffer t...

Up next
Tour Andromeda: how to screen for optimal expression of folded membrane proteins in crude lysate
Tour Andromeda: how to screen for optimal expression of folded membrane proteins in crude lysate

Poor expression levels, solubilization, and stability — these are the daily challenges that your membrane p...

×

Sign up to receive
the latest NanoTemper news, product updates, event announcements and more

First Name
Last Name
Company Name
Country
State
Province
State
Region
State
Canton
Agree to Subscribe & Privacy Policy*
*I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
Thank you!
Error - something went wrong!